Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 May;23(3):389-408.
doi: 10.1007/s10741-018-9682-3.

Interrelationship between diabetes mellitus and heart failure: the role of peroxisome proliferator-activated receptors in left ventricle performance

Evangelos Oikonomou  1 , Konstantinos Mourouzis  2 , Petros Fountoulakis  2 , Georgios Angelos Papamikroulis  2 , Gerasimos Siasos  2 , Alexis Antonopoulos  2 , Georgia Vogiatzi  2 , Sotiris Tsalamadris  2 , Manolis Vavuranakis  2 , Dimitris Tousoulis  2
Affiliations
Review

Interrelationship between diabetes mellitus and heart failure: the role of peroxisome proliferator-activated receptors in left ventricle performance

Evangelos Oikonomou et al. Heart Fail Rev. 2018 May.

Abstract

Heart failure (HF) is a common cardiac syndrome, whose pathophysiology involves complex mechanisms, some of which remain unknown. Diabetes mellitus (DM) constitutes not only a glucose metabolic disorder accompanied by insulin resistance but also a risk factor for cardiovascular disease and HF. During the last years though emerging data set up, a bidirectional interrelationship between these two entities. In the case of DM impaired calcium homeostasis, free fatty acid metabolism, redox state, and advance glycation end products may accelerate cardiac dysfunction. On the other hand, when HF exists, hypoperfusion of the liver and pancreas, b-blocker and diuretic treatment, and autonomic nervous system dysfunction may cause impairment of glucose metabolism. These molecular pathways may be used as therapeutic targets for novel antidiabetic agents. Peroxisome proliferator-activated receptors (PPARs) not only improve insulin resistance and glucose and lipid metabolism but also manifest a diversity of actions directly or indirectly associated with systolic or diastolic performance of left ventricle and symptoms of HF. Interestingly, they may beneficially affect remodeling of the left ventricle, fibrosis, and diastolic performance but they may cause impaired water handing, sodium retention, and decompensation of HF which should be taken into consideration in the management of patients with DM. In this review article, we present the pathophysiological data linking HF with DM and we focus on the molecular mechanisms of PPARs agonists in left ventricle systolic and diastolic performance providing useful insights in the molecular mechanism of this class of metabolically active regiments.

Keywords: Diabetes mellitus; Diastolic dysfunction; Heart failure; Peroxisome proliferator-activated receptors; Systolic dysfunction; Thiazolidinediones.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Nutr J. 2014 Feb 14;13:17 - PubMed
    1. Am J Physiol Heart Circ Physiol. 2006 Jul;291(1):H81-7 - PubMed
    1. Circulation. 2015 Jun 16;131(24):e535 - PubMed
    1. Mitochondrion. 2018 Jan 4;:null - PubMed
    1. Recent Prog Horm Res. 2001;56:265-94 - PubMed

MeSH terms

Substances

LinkOut - more resources